ALS acquires Invitek Molecular GmbH

DNA Helix
19 JAN 2023 ALS
Founded in 1992 as one of the first biotech companies in Berlin, Germany, Invitek Molecular develops and commercializes tailor-made nucleic acid purification solutions enabling manual and automated DNA/RNA extraction from virtually any sample material. Invitek Molecular also provides customized development and contract manufacturing services to in-vitro diagnostics companies globally, covering all challenges from concept to marketable product realization.
 
With a solid technical reputation and over 30 years of experience, Invitek Molecular will build upon ALS’ diagnostics division offering clients a complete one-stop-shop solution.
 
Managing Director and CEO, Raj Naran commented, “This acquisition represents ALS’ commitment to growing our diagnostics capabilities and services, delivering robust solutions to our clients.”
 
Learn more about Invitek Molecular